Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis.
about
Antioxidants and endothelial dysfunction in hyperlipidemia.Topical non-iontophoretic application of acetylcholine and nitroglycerin via a translucent patch: a new means for assessing microvascular reactivity.Increased expression of endothelin ET(B) and angiotensin AT(1) receptors in peripheral resistance arteries of patients with suspected acute coronary syndrome.Visfatin versus Flow-Mediated Dilatation as a Marker of Endothelial Dysfunction in Pediatric Renal Transplant RecipientsThe renin angiotensin system as a risk factor for coronary artery disease.Valsartan improves endothelial dysfunction in hypertension: a randomized, double-blind study.Vascular endothelial function and hypertension: insights and directionsImpaired relaxation of cerebral arteries in the absence of elevated salt intake in normotensive congenic rats carrying the Dahl salt-sensitive renin gene.Therapeutic potential of angiotensin II receptor antagonists.Central role of the AT(1)-receptor in atherosclerosis.Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis.Endothelial dysfunction and cardiovascular disease.Comparison of the effect of enalapril and losartan in conjunction with surgical coronary revascularisation versus revascularisation alone on systemic endothelial function.Endothelial dysfunction: cardiovascular risk factors, therapy, and outcomeEffects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variants.Differential effects of AT1 receptor and Ca2+ channel blockade on atherosclerosis, inflammatory gene expression, and production of reactive oxygen speciesPharmacological basis of different targets for the treatment of atherosclerosis.Targeting nitric oxide with drug therapy.Effect of Angiotensin II Type I Receptor Blockade with Valsartan on Carotid Artery Atherosclerosis: A Double Blind Randomized Clinical Trial Comparing Valsartan and Placebo (EFFERVESCENT)Pharmacogenomics of renin angiotensin system inhibitors in coronary artery disease.Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-Losartan improves impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type 1 diabetic rats.Vascular endothelial function and self-reported sleep.Endothelial function and aminothiol biomarkers of oxidative stress in healthy adultsImpact of spironolactone on endothelial function in patients with single ventricle heart.Current pharmacotherapeutic concepts for the treatment of cardiovascular disease in diabetics.Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis.Salt, Angiotensin II, Superoxide, and Endothelial Function.Endothelial Dysfunction and Hypertension.Review: Interaction among angiotensin II, nitric oxide and oxidative stress.AT1 receptor signaling pathways in the cardiovascular system.Olmesartan improves endothelial function in hypertensive patients: link with extracellular superoxide dismutase.Systemic Vascular Transduction by Capsid Mutant Adeno-Associated Virus After Intravenous Injection.Endothelial function during stimulation of renin-angiotensin system by low-sodium diet in humans.Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria.Anti-atherosclerotic efficacy of olmesartan.Angiotensin II-induced modulation of endothelium-dependent relaxation in rabbit mesenteric resistance arteries.Chronic AT(1) receptor blockade alters mechanisms mediating responses to hypoxia in rat skeletal muscle resistance arteries.Candesartan cilexetil protects cavernous tissue in spontaneously hypertensive rats.
P2860
Q31935120-6739073A-367B-4E59-A006-EADBA3E2B402Q33299320-35DA94D0-6F67-4D40-B42D-A82902EC903EQ33527029-92E5C4F2-2236-4581-9E53-BEC9DD142C3AQ33646130-7E2244F8-A8C6-40C8-A793-55E390D5D6D8Q34140718-BE85B411-3DF0-43D5-9151-9EF2A54B3BC2Q34167806-54AE8579-6E6D-4852-8BD8-17C0831A3879Q34316160-8DA30D23-6AEE-4024-B66B-0A5B9CE5C575Q34426146-3F0560B9-CFC3-4B7F-A328-47C65A6A9209Q34481715-DBFA4CDB-962A-4A88-9EF8-141ED56154F4Q34761161-74AE9BAF-3E33-4826-AF25-E9714E536B02Q35038207-88C57082-3AC9-44DD-9407-E5900FEC5FB5Q35156621-B45C74DC-C1A5-46F4-8877-3FF4C1A943ADQ35584458-1FDBE75D-A655-4856-98B7-CB7523FC5353Q36012867-8BC5E85D-CEFA-4EEE-BA63-A92788AA6997Q36087990-DE3CE28A-C7E3-44BA-A65B-59EC83399D55Q36276106-B93C86E8-5A0E-4EB0-9728-CA40BFCB8B0EQ36346487-99AFE01C-6D33-47E5-9138-EB4F2C525C4FQ36684790-07C01633-8633-492F-AA69-2263E82E4736Q36708368-03F911C1-8FB9-4556-9EF2-7F127BE75790Q36814406-CF4134D3-1767-4484-8495-906B4F1C186AQ36857263-396F5E7C-1246-4D18-90FC-AE85195A09ADQ37194141-BE99E675-1A5F-455F-AA6E-BDC9ECF4304EQ37250956-5A3E3EC6-6AB0-41DE-BEE7-9DE55CAF5F4CQ37366164-C25A4ED4-9A99-4021-AE11-DE7E5CB5193DQ37535308-91B85361-7BF9-4BD9-A617-B0406CD50DA0Q37535313-1EC370B7-AA16-4FD8-820C-D75EAFB9CAFFQ37645663-470DEAD5-F187-4A08-B3C5-CB0A44A77B1FQ37958283-1CB0C84B-31B7-45E7-A242-3FDD1ADF0AF1Q38693277-577DB407-F67B-4103-AEEB-D034D9B3A321Q38776339-91E4B0D7-F1AD-4E07-8267-FD4E8C6941A7Q39092011-7C9C46F5-C5BD-46AB-A505-57DE734EE2D0Q39319793-8EB64A33-C326-4EC3-92E2-5C65DB822328Q39784603-182440C5-BEEF-419E-9D06-6BFBBA1EC992Q41375421-406D0442-1743-4352-B91C-6831C30CAC16Q43572774-C7BCAA7C-00C6-4E72-8D7A-50329C008A88Q43938795-28A526C8-B82C-468D-A94F-00E319CFD0C3Q43967976-7F5A5FF9-4F69-42ED-B807-D14AFEFBCA3FQ44372219-1F93FA4B-8405-4FE1-B3BF-B2AD4FE478A7Q44814400-9273C944-FDF4-4C8D-B1CE-3D0A0765F6DBQ44855219-A8DFB30D-C1B1-4E12-9D7F-6947125701E1
P2860
Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Acute and chronic angiotensin- ...... ysfunction in atherosclerosis.
@en
Acute and chronic angiotensin- ...... ysfunction in atherosclerosis.
@nl
type
label
Acute and chronic angiotensin- ...... ysfunction in atherosclerosis.
@en
Acute and chronic angiotensin- ...... ysfunction in atherosclerosis.
@nl
prefLabel
Acute and chronic angiotensin- ...... ysfunction in atherosclerosis.
@en
Acute and chronic angiotensin- ...... ysfunction in atherosclerosis.
@nl
P2093
P1433
P1476
Acute and chronic angiotensin- ...... ysfunction in atherosclerosis.
@en
P2093
Ellahham S
Mincemoyer R
Quyyumi AA
Schenke WH
Tupas-Habib T
Waclawin MA
P304
P356
10.1161/01.CIR.101.20.2349
P407
P577
2000-05-01T00:00:00Z